Search Results
May 27, 2026, 08:00 ET Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® (Taletrectinib) in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting
QTc.Hyperuricemia: Hyperuricemia can occur and was reported in 14% of patients, with 16% of these requiring urate-lowering medication without pre-existing gout or hyperuricemia. 0.3% of patients experienced Grade ≥3. Median time to first onset was 2.1 months (range: 7 days to 35.8 months). Dose
More news about: Nuvation Bio Inc.
May 27, 2026, 07:24 ET Merach S29R2: samonapájací rotoped oslobodzuje používateľov od mesačného predplatného na fitness
platformám pre virtuálnu cyklistiku bicykel automaticky upravuje odpor podľa zmien terénu v reálnom čase a reaguje do troch sekúnd, aby simuloval stúpania, zjazdy a meniace sa jazdné podmienky. Systém obsahuje aj sedem prednastavených automatických tréningových programov.Navrhnuté pre každodenné
More news about: Merach
May 27, 2026, 07:02 ET ixlayer Appoints Helmut Osorio as General Manager to Accelerate Direct-to-Patient Growth for Biopharma
exciting."Osorio earned an MBA in Marketing and Finance from the Ross School of Business at the University of Michigan and a bachelor's degree in Psychology and Pre-Med from the University of Michigan. He is bilingual in English and Spanish.About ixlayerixlayer [pronounced: I-X-layer] is the
More news about: ixlayer
May 27, 2026, 07:01 ET FANUC America Debuts Cobot and Go Booth with Rapid Deployment Automation Solutions at Automate 2026
/PRNewswire/ -- FANUC America will debut a dedicated Cobot and Go booth (#1001) at Automate 2026, June 22–26 at McCormick Place in Chicago, featuring pre-engineered collaborative robot systems built for rapid deployment and developed with leading system integrators and distributors.
More news about: Fanuc America Corporation
May 27, 2026, 07:01 ET ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening
quality incentives."Colorectal cancer is highly treatable when caught early – survivable in about 90% of cases – and is even preventable when pre-cancers are found and removed. But still, up to 60 million eligible Americans remain unscreened," said Dr. Xavier Llor, professor of medicine and director,
More news about: Abbott
May 27, 2026, 07:00 ET Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
[2]About BRII-179BRII-179 is a novel recombinant protein-based HBV immunotherapeutic candidate that expresses the Pre-S1, Pre-S2, and S HBV surface antigens, designed to induce enhanced and broad B-cell and T-cell immunity. In November 2023, the Center for Drug Evaluation
More news about: Brii Biosciences Limited
May 27, 2026, 07:00 ET 騰盛博藥在EASL 2026發布ENSURE II期研究最新突破性數據，進一步支持BRII‑179對實現乙肝病毒持久免疫學控制的潛在作用
1中國慢性HBV感染人數達8,700萬，非常值得關注。[2]關於BRII-179BRII-179是一種基於重組蛋白質的新型HBV免疫治療候選藥物，可表達HBV的Pre-S1、Pre-S2和S表面抗原，旨在誘導增強和廣泛的B細胞和T細胞免疫應答。2023年11月，中國國家藥品監督管理局（NMPA）藥品審評中心（CDE）授予BRII-179突破性療法認定。關於ElebsiranElebsiran是一種經皮下注射給藥的靶向乙型肝炎病毒（HBV）的小干擾核糖核酸（siRNA）研究性藥物，旨在降解HBV
More news about: 騰盛博藥生物科技有限公司
May 27, 2026, 07:00 ET BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
clinical trial of GLIX1 in glioblastoma," stated Philip Serlin, Chief Executive Officer of BioLineRx. "We are also very encouraged by compelling new pre-clinical data showing that GLIX1 demonstrated robust dose-dependent tumor-growth inhibition and survival benefit in orthotopic cell-derived xenograft
More news about: BioLineRx Ltd.
May 27, 2026, 07:00 ET DICK'S Sporting Goods, Inc. Reports First Quarter Results
—Reconciliation to pre-tax income
More news about: DICK'S Sporting Goods, Inc.
May 27, 2026, 07:00 ET Luvme Hair Shares Expert Tips for Secure Wig Wear Without Glue
wig sit evenly on the head and prevents bumps that may affect the final look. This step is especially important for lace front wigs, HD lace wigs, and pre-cut lace wigs, where a smooth foundation can help the lace lay more naturally along the hairline.4. Place the Wig Carefully Along the HairlineFor
More news about: Luvme Hair
May 27, 2026, 07:00 ET Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States
reach cash flow break-even, and the Company's ability to commence clinical studies or complete ongoing clinical studies for the Company's clinical and pre-clinical stage candidates. The Company has no obligation to provide any updates to these forward-looking statements even if its expectations change.
More news about: Precigen, Inc.
May 27, 2026, 07:00 ET Defense Metals and Hanwha Corporation Sign Non-Binding Memorandum of Understanding To Advance Domestic Rare Earth Supply Chain
advanced, undeveloped REE deposits in North America or Europe, featuring a robust mineral resource and mining reserve, as detailed in the Company's 2025 Pre Feasibility Study ("PFS"; refer to Company News Release April 7th, 2025) prepared in accordance with National Instrument 43-101 Standards
More news about: Defense Metals Corp.
May 27, 2026, 06:40 ET Dizal's ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer
across 16 countries and regions evaluating ZEGFROVY as first-line treatment for patients with EGFR exon20ins NSCLC, met its primary endpoint.Pre-clinical and clinical results of ZEGFROVY were published in peer-reviewed journals including Cancer Discovery, The Lancet Respiratory Medicine
More news about: Dizal Pharmaceutical
May 27, 2026, 06:30 ET Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC
inhibitor (TKI) pre-treated patients with advanced ALK-positive non-small cell lung cancer (NSCLC) enrolled in the global registrational ALKOVE-1 Phase 1/2 clinical trial, the U.S. Food and Drug Administration (FDA) has accepted for filing Nuvalent's NDA submission for neladalkib in TKI pre-treated advanced
More news about: Nuvalent, Inc.
May 27, 2026, 06:00 ET ezW2Correction 2025 Launches With E-File Direct Add-On Feature
submissionProcess multiple tax years (2015–2025) at one flat ratePrint forms on plain white paper, no pre-printed forms requiredUnlimited corrections with no extra feesGenerate secure PDF copies for digital
More news about: Halfpricesoft.com
May 27, 2026, 06:00 ET BMO Financial Group Reports Second Quarter 2026 Results
acquisition of Burgundy, which reduced non-interest revenue in the current quarter by $7 million (pre-tax and after-tax), recorded in Wealth Management. Q1-2026 included a reduction of $16 million (pre-tax and after-tax). For further information, refer to Note 13 of the unaudited interim consolidated
More news about: BMO Financial Group
May 27, 2026, 06:00 ET BMO Financial Group Reports Second Quarter 2026 Results
acquisition of Burgundy, which reduced non-interest revenue in the current quarter by $7 million (pre-tax and after-tax), recorded in Wealth Management. Q1-2026 included a reduction of $16 million (pre-tax and after-tax). For further information, refer to Note 13 of the unaudited interim consolidated
More news about: BMO Financial Group
May 27, 2026, 06:00 ET WHERE DOES YOUR DOG HIDE DURING STORMS?
learn more and see if there's a participating veterinary study site nearby. Owners who believe their dogs may qualify should complete a short online pre-screening questionnaire, which helps determine whether their dogs may be eligible for an in-person evaluation by a trained Study Veterinarian.Time
More news about: Dog Storm Study
May 27, 2026, 05:52 ET Global Bakery Mixes Market Outlook 2026-2036: Production Standardization and Process Efficiency Drive Growth for General Mills, Puratos Group, and Dawn Foods
As bakeries and foodservice chains face rising operational costs and tighter labor availability, demand for pre-formulated bakery mixes is accelerating. Manufacturers are increasingly focusing on process efficiency, waste reduction, and product consistency through
More news about: Future Market Insights
May 27, 2026, 05:14 ET WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities
co-formulation, and large-volume device solutions, the company offers a full range of delivery formats, including liquid and lyophilized vial formulations, pre-filled syringes (PFS), dual-chamber cartridges (DCC), and a variety of safety and automated combination products. These capabilities are supported by
More news about: WuXi Biologics
May 27, 2026, 04:43 ET Foresee Pharmaceuticals Announces Completion of Casppian Phase 3 Study with Last Patient Last Visit and Confirms Topline Results: 94% of Patients Achieve LH Suppression with 6-Month Dosing Interval of Leuprolide Mesylate, also the acceptance of Casppian Study for Presentation at Endocrine Society, ENDO 2026 Medical Conference, as a Potential New Six-Month Treatment Option for Central Precocious Puberty
The results were statistically significant (P-value = 0.0005), with 94% of patients achieving LH suppression below the threshold, far exceeding the pre-specified success criterion of 80%. FP-001 42 mg was well tolerated, with a safety profile consistent with the established class of GnRH agonists. With
More news about: Foresee Pharmaceuticals Co., Ltd.
May 27, 2026, 04:38 ET Kuaishou Technology Announces First Quarter 2026 Unaudited Financial Results
diverse online marketing services scenarios, covering the full pre-placement, in-placement and post-placement cycle. This improved clients' placement experience and drove growth in total spending from online marketing services. In the pre-placement stage, the generation of AIGC marketing materials enabled
More news about: Kuaishou Technology
May 27, 2026, 04:13 ET Infortrend to Showcase Next-Generation AI Infrastructure from Edge to Cloud at COMPUTEX 2026
insights at the moment they matter, without routing everything through the data center. It is available either as Bare-Metal Hardware, or as a pre-integrated hardware and software solution supporting three deployment modes—
More news about: Infortrend Technology
May 27, 2026, 03:00 ET Lightera and Nokia Announce Collaboration to Accelerate Optical LAN Adoption in Europe
solutions with Nokia's GPON, XGS-PON, and 25G-PON technologies. The companies' integrated solution will include end-to-end support services such as pre-sales consulting, start-up services, and 24x7 technical support and training.By working with its ecosystem of integrators and channel partners,
More news about: Lightera, LLC
May 27, 2026, 02:28 ET Hansa Biopharma reports positive efficacy and safety results from Idefirix® European post authorization study in kidney transplantation
objective of the PAES was met, with 90% of highly sensitized kidney transplant patients achieving one-year graft failure-free survival following Idefirix pre-treatment to convert a positive crossmatch against a deceased donor to negative prior to transplantation.Secondary objectives included evaluation
More news about: Hansa Biopharma AB